Dupilumab reduces severe asthma exacerbations

J Pediatr. 2022 Jun:245:246-249. doi: 10.1016/j.jpeds.2022.02.039.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Humans

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • dupilumab